Moreover, another study in breast cancer cells has shown that NDRG1 silencing leads to reduction of cell proliferation rate, abnormalities in lipid metabolism such as enhancement of incorporation of fatty acids into neutral lipids and lipid droplets. The gene discussed is NDRG1; the disease is breast cancer.